发明名称 Pharmaceutical composition for oral use with improved absorption
摘要 The present invention relates to an agent for inhibiting decomposition of a biologically active peptide by a digestive enzyme, which is aminoalkyl methacrylate coplolymer E as an effective ingredient, and an agent for reducing viscosity of the gastrointestinal mucosa and mucous layers distributed over this mucosa. The present invention relates to a method for inhibiting decomposition of a biologically active peptide by a digestive enzyme, or a method for reducing viscosity of the gastrointestinal mucosa and/or mucous layers distributed over the mucosa, by administration of aminoalkyl methacrylate copolymer E. Furthermore, the present invention relates to a pharmaceutical composition for oral use with improved absorption, which comprises a biologically active peptide and aminoalkyl methacrylate copolymer E. Excellent oral absorption of a biologically active peptide that were considered difficult to absorb by oral administration in the past, can be realized based on the ability to inhibit decomposition of a biologically active peptide, the ability to reduce viscosity of the gastrointestinal mucosa and/or mucous layers distributed over this mucosa, and the ability to improve permeability of a biologically active peptide in the gastrointestinal mucosa and/or mucous layers of the pharmaceutical composition of the present invention.
申请公布号 US2003175351(A1) 申请公布日期 2003.09.18
申请号 US20030345051 申请日期 2003.01.15
申请人 YAMANOUCHI PHARMACEUTICAL CO., LTD. 发明人 WATANABE SHUNSUKE;NAKANISHI KIYO;TAKEMURA SHIGEO;TSUTSUI YUUKI
分类号 A61K9/00;A61K9/20;A61K9/28;A61K9/48;A61K31/785;A61K38/11;A61K38/22;A61K38/23;A61K38/28;A61K47/32;A61P43/00;(IPC1-7):A61K9/14 主分类号 A61K9/00
代理机构 代理人
主权项
地址